Shanghai Pharmaceuticals Holding Co., Ltd
601607
Hisse Senetlerindeki Sıralama
#2386
Shanghai Pharmaceuticals Holding Co., Ltd., a diversified investment holding... Shanghai Pharmaceuticals Holding Co., Ltd., a diversified investment holding entity established in 1994 and headquartered in Shanghai, China, plays a crucial role in the People's Republic of China's pharmaceutical and healthcare sectors. As a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd., its extensive operations encompass research, development, manufacturing, distribution, and retail of a wide array of products. The company's business model is structured around four principal segments: Production, Distribution, Retail, and an 'Others' category. Within its Production segment, it develops and manufactures a broad portfolio of pharmaceuticals, including chemical and biochemical drugs, traditional Chinese medicines, healthcare solutions, and medical devices. These offerings target diverse therapeutic fields such as oncology, cardiovascular and cerebrovascular conditions, central nervous system disorders, general infections, immunological diseases, digestive and metabolic ailments, and respiratory issues. The company's product range comprises approximately 700 distinct drug varieties. Beyond manufacturing, its Distribution arm is instrumental in providing comprehensive pharmaceutical supply chain solutions. This includes warehousing, logistics, and value-added services for various industry players, from pharmaceutical manufacturers to dispensers like hospitals, other distributors, and retail pharmacies. Furthermore, the company manages an extensive network of retail pharmacies, alongside a burgeoning online drug sales platform. This retail footprint spans approximately 2,000 chain pharmacies across 24 provinces. Its 'Others' segment encompasses a variety of support and innovative services, such as consulting, asset management, clinical trial coordination, medical assistance programs, educational initiatives for healthcare professionals and patients, e-prescription management systems, and the development of remote and cloud hospital technologies.
Hisse Fiyatı
$2.43
Piyasa Değeri
$8.09B
Değişim (1 gün)
-1.16%
Değişim (1 yıl)
-5.94%
Ülke
CN
Ticaret Shanghai Pharmaceuticals Holding Co., Ltd (601607)
Kategori
Healthcare
Shanghai Pharmaceuticals Holding Co., Ltd (601607) için hisse bölünme geçmişi
Shanghai Pharmaceuticals Holding Co., Ltd hissesi (sembol: 601607) toplamda 5 hisse bölünmesi yaşamıştır.
En son hisse bölünmesi Aug 16, 2007 tarihinde gerçekleşmiştir.
Jun 09, 1997 tarihinden önce alınan bir 601607 hissesi bugün 4.7378925 601607 hissesine eşdeğerdir.
En son hisse bölünmesi Aug 16, 2007 tarihinde gerçekleşmiştir.
Jun 09, 1997 tarihinden önce alınan bir 601607 hissesi bugün 4.7378925 601607 hissesine eşdeğerdir.
Hisse bölünme listesi
| Yıl | Bölünme | Çarpan | Kümülatif Çarpan |
|---|---|---|---|
| 2007-08-16 | 6:5 | x1.2 | x4.7378925 |
| 2003-06-19 | 3:2 | x1.5 | x3.94824375 |
| 2001-05-15 | 23397:20000 | x1.16985 | x2.6321625 |
| 1999-05-06 | 3:2 | x1.5 | x2.25 |
| 1997-06-09 | 3:2 | x1.5 | x1.5 |
Benzer şirketler veya rakipler için hisse bölünmeleri
| Şirket | Hisse bölünme sayısı | Kümülatif Çarpan | Ülke |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 11 | x12 |
US
|
|
| 0 | - |
US
|
|
| 3 | x5 |
AU
|
